References
- Strasser S. I., McDonald G. B. Gastrointestinal and hepatic complications. Hematopoietic Cell Transplantation, E D Thomas, K G Blume, S J Forman. Blackwell Science, Massachusetts 1998; 627–658
- Sniecinski I. J., O'Donnell M. R. Hemolytic complications of hematopoietic cell transplantation. Hematopoietic Cell Transplantation, E D Thomas, K G Blume, S J Forman. Blackwell Science, Massachusetts 1998; 674–684
- Kearon C., Ginsberg J. S., Hirsh J. Venus thromboembolic disease. Evidence Based Cardiology, S Yusuf, J A Cairns, A J Camm. BMJ Books, London 1998; 1009–1024
- Leblond V., Salehian B. D., Borel C. Alterations in natural anticoagulant levels during allogeneic bone marrow transplantation: a prospective study in 27 patients. Bone Marrow Transplantation 1993; 11: 299–305
- Faioni E. M., Krachmalnicoff A., Bearman S. I. Naturally occurring anticoagulants and bone marrow transplantation: plasma protein C predicts the development of venocclusive disease of the liver. Blood 1993; 81: 3458–3462
- Mortimer J. E., Hewlett J. S., Bay J., Livingston R. B. High dose BCNU with autologous bone marrow rescue in the treatment of recurrent malignant gliomas. Journal of Neurooncology 1983; 1: 269–273
- Hyers T. M., Hull R. D., Weg J. G. Antithrombotic therapy for venous thromboembolic disease. Chest 1995; 108: 335S–351S, (Suppl)
- Decousus H., Leizorovicz A., Parent F. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. New England Journal of Medicine 1998; 338: 409–415
- Ferris E. J., McCowan T. C., Carver D. K., McFarland D. R. Percutaneous inferior vena caval filters: follow-up of seven designs in 320 patients. Radiology 1993; 188: 851–856
- Athanasouilis C. A. Complications of vena caval filters. Radiology 1993; 188: 614–615
- Zwaan M., Lorch H., Kulke C. Clinical experiences with temporary vena caval filters. JVIR 1998; 9: 594–601
- Millward S. F. Temporary and retrievable inferior vena cava filters: Current status. JVIR 1998; 9: 381–387